134 related articles for article (PubMed ID: 32436301)
1. Immunization with cytolethal distending toxin B produces autoantibodies to vinculin and small bowel bacterial changes in a rat model of postinfectious irritable bowel syndrome.
Morales W; Triantafyllou K; Parodi G; Weitsman S; Park SC; Rezaie A; Pichetshote N; Lin E; Pimentel M
Neurogastroenterol Motil; 2020 Oct; 32(10):e13875. PubMed ID: 32436301
[TBL] [Abstract][Full Text] [Related]
2. Autoimmunity Links Vinculin to the Pathophysiology of Chronic Functional Bowel Changes Following Campylobacter jejuni Infection in a Rat Model.
Pimentel M; Morales W; Pokkunuri V; Brikos C; Kim SM; Kim SE; Triantafyllou K; Weitsman S; Marsh Z; Marsh E; Chua KS; Srinivasan S; Barlow GM; Chang C
Dig Dis Sci; 2015 May; 60(5):1195-205. PubMed ID: 25424202
[TBL] [Abstract][Full Text] [Related]
3. Gut microbiota profiles and the role of anti-CdtB and anti-vinculin antibodies in patients with functional gastrointestinal disorders (FGID).
Vasapolli R; Schulz C; Schweden M; Casèn C; Kirubakaran GT; Kirste KH; Macke L; Link A; Schütte K; Malfertheiner P
Eur J Clin Invest; 2021 Dec; 51(12):e13666. PubMed ID: 34390492
[TBL] [Abstract][Full Text] [Related]
4. Assessment of Anti-vinculin and Anti-cytolethal Distending Toxin B Antibodies in Subtypes of Irritable Bowel Syndrome.
Rezaie A; Park SC; Morales W; Marsh E; Lembo A; Kim JH; Weitsman S; Chua KS; Barlow GM; Pimentel M
Dig Dis Sci; 2017 Jun; 62(6):1480-1485. PubMed ID: 28451914
[TBL] [Abstract][Full Text] [Related]
5. Circulating Anti-cytolethal Distending Toxin B and Anti-vinculin Antibodies as Biomarkers in Community and Healthcare Populations With Functional Dyspepsia and Irritable Bowel Syndrome.
Talley NJ; Holtmann G; Walker MM; Burns G; Potter M; Shah A; Jones M; Koloski NA; Keely S
Clin Transl Gastroenterol; 2019 Jul; 10(7):e00064. PubMed ID: 31356481
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of a biomarker for diarrhea-predominant irritable bowel syndrome in human subjects.
Pimentel M; Morales W; Rezaie A; Marsh E; Lembo A; Mirocha J; Leffler DA; Marsh Z; Weitsman S; Chua KS; Barlow GM; Bortey E; Forbes W; Yu A; Chang C
PLoS One; 2015; 10(5):e0126438. PubMed ID: 25970536
[TBL] [Abstract][Full Text] [Related]
7. Cytolethal distending toxin B inoculation leads to distinct gut microtypes and IBS-D-like microRNA-mediated gene expression changes in a rodent model.
Leite G; de Freitas Germano J; Morales W; Weitsman S; Barlow GM; Parodi G; Pimentel ML; Villanueva-Millan MJ; Sanchez M; Ayyad S; Rezaie A; Mathur R; Pimentel M
Gut Microbes; 2024; 16(1):2293170. PubMed ID: 38108386
[TBL] [Abstract][Full Text] [Related]
8. Second-Generation Biomarker Testing for Irritable Bowel Syndrome Using Plasma Anti-CdtB and Anti-Vinculin Levels.
Morales W; Rezaie A; Barlow G; Pimentel M
Dig Dis Sci; 2019 Nov; 64(11):3115-3121. PubMed ID: 31152332
[TBL] [Abstract][Full Text] [Related]
9. Study of Antibodies to Cytolethal Distending Toxin B (CdtB) and Antibodies to Vinculin in Patients with Irritable Bowel Syndrome.
Zaki MES; Elhammady D; Foda Salama M; Abdelsalam M; Osman AOB
F1000Res; 2021; 10():303. PubMed ID: 34754418
[No Abstract] [Full Text] [Related]
10. Acute and chronic histological changes of the small bowel secondary to C. jejuni infection in a rat model for post-infectious IBS.
Morales W; Pimentel M; Hwang L; Kunkel D; Pokkunuri V; Basseri B; Low K; Wang H; Conklin JL; Chang C
Dig Dis Sci; 2011 Sep; 56(9):2575-84. PubMed ID: 21409374
[TBL] [Abstract][Full Text] [Related]
11. The human translation of the postinfectious irritable bowel syndrome like rat model with antivinculin production after immunization with cytolethal distending toxin B.
Schmulson M; Davalos De la Rosa MF; Linares-Garcia L; Morales-Guzmán AS; Balbuena R; Lau C
Neurogastroenterol Motil; 2021 Jan; 33(1):e14042. PubMed ID: 33232542
[No Abstract] [Full Text] [Related]
12. Carriage of CdtB Encoding Campylobacter spp., Salmonella enterica, and Yersinia entercolitica in Patients with Gastroenteritis and Irritable Bowel Syndrome.
Ganji L; Shirazi MH; Ebrahimi-Daryani N; Eslami P; Rahbar M; Zali MR; Alebouyeh M
Dig Dis Sci; 2022 Dec; 67(12):5522-5528. PubMed ID: 35357609
[TBL] [Abstract][Full Text] [Related]
13. A definitive blood test for post-infectious irritable bowel syndrome?
Barlow GM; Rezaie A; Lin E; Pimentel M
Expert Rev Gastroenterol Hepatol; 2016 Nov; 10(11):1197-1199. PubMed ID: 27682513
[No Abstract] [Full Text] [Related]
14. Effect of repeated Campylobacter jejuni infection on gut flora and mucosal defense in a rat model of post infectious functional and microbial bowel changes.
Sung J; Morales W; Kim G; Pokkunuri V; Weitsman S; Rooks E; Marsh Z; Barlow GM; Chang C; Pimentel M
Neurogastroenterol Motil; 2013 Jun; 25(6):529-37. PubMed ID: 23521493
[TBL] [Abstract][Full Text] [Related]
15. Microbiome and Its Role in Irritable Bowel Syndrome.
Pimentel M; Lembo A
Dig Dis Sci; 2020 Mar; 65(3):829-839. PubMed ID: 32026278
[TBL] [Abstract][Full Text] [Related]
16. Reaction of antibodies to
Vojdani A; Vojdani E
World J Gastroenterol; 2019 Mar; 25(9):1050-1066. PubMed ID: 30862994
[TBL] [Abstract][Full Text] [Related]
17. ICC density predicts bacterial overgrowth in a rat model of post-infectious IBS.
Jee SR; Morales W; Low K; Chang C; Zhu A; Pokkunuri V; Chatterjee S; Soffer E; Conklin JL; Pimentel M
World J Gastroenterol; 2010 Aug; 16(29):3680-6. PubMed ID: 20677340
[TBL] [Abstract][Full Text] [Related]
18. No difference in serum levels of B-cell activating receptor and antibodies against cytolethal distending toxin B and flagellin in post-infectious irritable bowel syndrome and chronic fatigue syndrome after
Hanevik K; Saghaug C; Aaland M; Morch K; Langeland N
JGH Open; 2022 Mar; 6(3):185-188. PubMed ID: 35355666
[TBL] [Abstract][Full Text] [Related]
19. [Preparation and characterization of monoclonal antibodies against cytolethal distending toxin protein of Campylobacter jejuni].
Lu L; Shang Y; Ren F; Wang N; Jiao X; Huang J
Wei Sheng Wu Xue Bao; 2014 Aug; 54(8):950-5. PubMed ID: 25345028
[TBL] [Abstract][Full Text] [Related]
20. A new rat model links two contemporary theories in irritable bowel syndrome.
Pimentel M; Chatterjee S; Chang C; Low K; Song Y; Liu C; Morales W; Ali L; Lezcano S; Conklin J; Finegold S
Dig Dis Sci; 2008 Apr; 53(4):982-9. PubMed ID: 17934822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
